-
Use of Online Communities among People with Type 2 Diabetes: A Scoping Review Curr. Diab. Rep. (IF 4.2) Pub Date : 2024-03-08
Abstract Purpose of Review People with diabetes require continuous self-monitoring and face numerous decisions in their day-to-day lives. Therefore, on many occasions, they need more support than that provided by health professionals. In this context, peer support in online diabetes communities could be a useful tool. The purpose of the review is to describe, analyze and synthesize the available evidence
-
Diabetes, SGLT-2 Inhibitors, and Urinary Tract Infection: a Review Curr. Diab. Rep. (IF 4.2) Pub Date : 2024-03-01 Reza Pishdad, Paul G. Auwaerter, Rita R. Kalyani
-
Diabetes Technology in People with Type 2 Diabetes: Novel Indications Curr. Diab. Rep. (IF 4.2) Pub Date : 2024-02-29
Abstract Purpose of Review Diabetes technology has been continuously evolving. Current versions of continuous glucose monitors (CGM) use minimally invasive designs, monitor glucose values with high accuracy, and can be used to guide insulin dosing. Extensive evidence supports the use of diabetes technology for monitoring and insulin administration in people with type 1 diabetes. However, there is emerging
-
Mapping Lifestyle Interventions for Gestational Diabetes Prevention: A Scoping Review Curr. Diab. Rep. (IF 4.2) Pub Date : 2024-02-17 Armando Peña, Alison M. Miller, Angela G. Campbell, Richard J. Holden, Christina M. Scifres
-
Exploring Technology’s Influence on Health Behaviours and Well-being in Type 1 Diabetes: a Review Curr. Diab. Rep. (IF 4.2) Pub Date : 2024-01-31 Reid D. McClure, Meryem K. Talbo, Anne Bonhoure, Joséphine Molveau, Courtney A. South, Maha Lebbar, Zekai Wu
-
Lessons and Applications of Omics Research in Diabetes Epidemiology Curr. Diab. Rep. (IF 4.2) Pub Date : 2024-01-31
Abstract Purpose of Review Recent advances in genomic technology and molecular techniques have greatly facilitated the identification of disease biomarkers, advanced understanding of pathogenesis of different common diseases, and heralded the dawn of precision medicine. Much of these advances in the area of diabetes have been made possible through deep phenotyping of epidemiological cohorts, and analysis
-
A Systematic Review of the Effects of Provider Bias on Health in Youth and Young Adults with Type 1 Diabetes Curr. Diab. Rep. (IF 4.2) Pub Date : 2024-01-18 Sara E. Wetter-Wren, Alexandra C. Himelhoch, Kimberly A. Driscoll
-
Polyagonists in Type 2 Diabetes Management Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-12-27 H. A. Dissanayake, N. P. Somasundaram
-
Factors Influencing Medication Adherence Among Adults Living with Diabetes and Comorbidities: a Qualitative Systematic Review Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-12-19 Kendall Gow, Amineh Rashidi, Lisa Whithead
Purpose of review Medication adherence plays an important role in improving health outcomes related to diabetes and comorbidity. The potential factors influencing medication adherence and how they contribute to health behaviors have not been synthesized to date. This review synthesized qualitative studies that identified factors influencing medication adherence among adults living with diabetes and
-
Exploring the Mechanistic Link Between Obesity and Heart Failure Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-12-15 Bige Ozkan, Chiadi E. Ndumele
-
Imeglimin: the New Kid on the Block Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-12-05 Sandeep Chandra Shrestha, Setu Gupta
-
Impact of the Neighborhood Food Environment on Dietary Intake and Obesity: a Review of the Recent Literature Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-11-27 Candice A. Myers
Purpose of Review The built environment impacts obesogenic behaviors and in turn body weight outcomes. This review summarizes recent research demonstrating environmental impacts on dietary intake and obesity with a specific focus on the neighborhood food environment. Recent Findings In the previous five years, an abundance of reviews and research studies have been undertaken to elucidate how the neighborhood
-
Obesity and Severity of Menopausal Symptoms: a Contemporary Review Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-11-24 Vivian Cao, Alisha Clark, Brooke Aggarwal
-
Positive Psychology Interventions for Improving Self-management Behaviors in Patients with Type 1 and Type 2 Diabetes: a Narrative Review of Current Evidence Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-11-01 Lihua Pan, Nelson C. Y. Yeung
-
Workplace Interventions for Type 2 Diabetes Mellitus Prevention—an Umbrella Review Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-09-20 Katarzyna Wnuk, Jakub Świtalski, Tomasz Tatara, Wojciech Miazga, Sylwia Jopek, Anna Augustynowicz, Urszula Religioni, Mariusz Gujski
-
How Could Taxes on Sugary Drinks and Foods Help Reduce the Burden Of Type 2 Diabetes? Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-09-11 Alan Reyes-García, Isabel Junquera-Badilla, Carolina Batis, M. Arantxa Colchero, J. Jaime Miranda, Tonatiuh Barrientos-Gutiérrez, Ana Basto-Abreu
-
Sexual Function and Satisfaction in the Context of Obesity Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-08-26 Sean M. McNabney, Nana Gletsu-Miller, David L. Rowland
Purpose of Review Sexual dysfunction is commonly associated with overweight/obesity, but the underlying physiological and psychosocial mechanisms are not fully understood. This review contextualizes the obesity-sexual (dys)function relationship, describes recent insights from the medical and social science literature, and suggests opportunities for continued research. Recent Findings Although sexual
-
The T1D Index: Implications of Initial Results, Data Limitations, and Future Development Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-08-23 Graham D. Ogle, Gabriel A Gregory, Fei Wang, Thomas IG Robinson, Jayanthi Maniam, Diana J Magliano, Trevor John Orchard
-
Sarcopenic Obesity and Cardiometabolic Health and Mortality in Older Adults: a Growing Health Concern in an Ageing Population Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-08-11 Sasiwarang Goya Wannamethee, Janice L. Atkins
-
Team-Based Approach to Reduce Malignancies in People with Diabetes and Obesity Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-08-03 Ziyue Zhu, Samuel Yeung Shan Wong, Joseph Jao Yiu Sung, Thomas Yuen Tung Lam
-
The Effectiveness of Cognitive Behavioral Therapy for Depression Among Individuals with Diabetes: a Systematic Review and Meta-Analysis Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-06-17 Qiuling An, Zhan Yu, Fei Sun, Jiaxuan Chen, Anao Zhang
-
Models Predicting Postpartum Glucose Intolerance Among Women with a History of Gestational Diabetes Mellitus: a Systematic Review Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-06-09 Yitayeh Belsti, Lisa Moran, Demelash Woldeyohannes Handiso, Vincent Versace, Rebecca Goldstein, Aya Mousa, Helena Teede, Joanne Enticott
-
Variations in the Design and Use of Attention Control Groups in Type 2 Diabetes Randomized Controlled Trials: a Systematic Review Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-06-09 Casey A. Droske, Triniece N. Pearson, Sharon J. Velkovich, Hannah Cohn, Jacqueline M. Kanoon, Arshiya A. Baig, Valerie G. Press
-
Does COVID-19 Infection Increase the Risk of Diabetes? Current Evidence Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-06-07 Rachel Wong, Emily Lam, Carolyn T. Bramante, Steven G. Johnson, Jane Reusch, Kenneth J. Wilkins, Hsin-Chieh Yeh
Purpose of Review Multiple studies report an increased incidence of diabetes following SARS-CoV-2 infection. Given the potential increased global burden of diabetes, understanding the effect of SARS-CoV-2 in the epidemiology of diabetes is important. Our aim was to review the evidence pertaining to the risk of incident diabetes after COVID-19 infection. Recent Findings Incident diabetes risk increased
-
Challenges and Opportunities in Diagnosis and Management of Cardiometabolic Risk in Adolescents Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-06-05 Dedeepya Konuthula, Marcia M. Tan, Deborah L. Burnet
-
Is Diabetes Mellitus a Predisposing Factor for Helicobacter pylori Infections? Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-05-22 Om Saswat Sahoo, Rhiti Mitra, Arghyadeep Bhattacharjee, Samarjit Kar, Oindrilla Mukherjee
-
The Impact of New and Renewed Restrictive State Abortion Laws on Pregnancy-Capable People with Diabetes Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-05-22 Ajleeta Sangtani, Lauren Owens, David T. Broome, Preethi Gogineni, William H. Herman, Lisa H. Harris, Lauren Oshman
Purpose of Review When the Supreme Court handed down its decision in Dobbs v Jackson Women’s Health Organization in June 2022, the constitutional right to abortion was no longer protected by Roe v Wade. Fifteen states now have total or near-total bans on abortion care or no clinics providing abortion services. We review how these restrictions affect the medical care of people with pregestational diabetes
-
Sleep Apnea, Obesity, and Diabetes — an Intertwined Trio Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-05-06 Soumya Kurnool, Karen C. McCowen, Nicole A. Bernstein, Atul Malhotra
-
Comparative Analysis of Clinical Practice Guidelines for the Pharmacological Treatment of Type 2 Diabetes Mellitus in Latin America Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-05-01 Paula Andrea Taborda Restrepo, Jorge Acosta-Reyes, Andrés Estupiñan-Bohorquez, María Alejandra Barrios-Mercado, Nestor Fabián Correa Gonzalez, Alejandra Taborda Restrepo, Noël C. Barengo, Rafael Gabriel
-
Prevalence of Diabetes in Patients with Hyperuricemia and Gout: A Systematic Review and Meta-analysis Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-04-26 Jinguo Jiang, Tingjing Zhang, Yashu Liu, Qing Chang, Yuhong Zhao, Chuanji Guo, Yang Xia
-
Using Mixed Methods Research in Children with Type 1 Diabetes: a Methodological Review Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-04-25 Sara L. Davis, Sarah S. Jaser, Nataliya V. Ivankova, Trey Lemley, Marti Rice
-
Implementation of Continuous Glucose Monitoring in Critical Care: A Scoping Review Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-04-13 Eileen R. Faulds, Kathleen M. Dungan, Molly McNett
-
Glucometrics: Where Are We Now? Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-04-13 Kelly Engle, Grace Bacani, Curtiss B. Cook, Gregory A. Maynard, Jordan Messler, Kristen Kulasa
-
Team-Based Diabetes Care in Ontario and Hong Kong: a Comparative Review Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-04-12 Calvin Ke, Emaad Mohammad, Juliana C. N. Chan, Alice P. S. Kong, Fok-Han Leung, Baiju R. Shah, Douglas Lee, Andrea O. Luk, Ronald C. W. Ma, Elaine Chow, Xiaolin Wei
-
Surgical Management of Diabetic Macular Edema Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-04-12 Jamie Prince, Dipen Kumar, Arko Ghosh, J. Fernando Arevalo, Alice Yang Zhang
-
Youth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-03-24 Isabella Marranzini Rodriquez, Katie L. O’Sullivan
Purpose of Review With the rise in prevalence of youth-onset type 2 diabetes (T2DM), it is imperative to understand the clinical burden of the disease and the socioeconomic burden this disease imposes. We review the most recent data on youth-onset T2DM, including its pathophysiology, complications, and treatment. We also review existing data to determine the socioeconomic burden of youth-onset T2DM
-
Weight Regain After Bariatric Surgery: Scope of the Problem, Causes, Prevention, and Treatment Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-02-08 Sabrena F. Noria, Rita D. Shelby, Katelyn D. Atkins, Ninh T. Nguyen, Kishore M. Gadde
Purpose of Review Although bariatric surgery is the most effective treatment of severe obesity, a proportion of patients experience clinically significant weight regain (WR) with further out from surgery. The purpose of this review is to summarize the prevalence, predictors, and causes of weight regain. Recent Findings Estimating the prevalence of WR is limited by a lack of consensus on its definition
-
The Role of Habit Formation and Automaticity in Diabetes Self-Management: Current Evidence and Future Applications Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-02-07 Jenine Y. Stone, Lindsay S. Mayberry, Kate Clouse, Shelagh Mulvaney
-
Recent Rates of Substance Use Among Adolescents and Young Adults with Type 1 Diabetes in the USA Curr. Diab. Rep. (IF 4.2) Pub Date : 2023-01-14 Rachna Sannegowda, Karina Villalba, Ryan Suk, Shilpa Gurnurkar, Rachel M. Wasserman
-
Implementation of Psychosocial Screening into Diabetes Clinics: Experience from the Type 1 Diabetes Exchange Quality Improvement Network Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-12-20 Sarah Corathers, Desiree Wilford, Jessica Kichler, Laura Smith, Emma Ospelt, Saketh Rompicherla, Alissa Roberts, Priya Prahalad, Marina Basina, Cynthia Muñoz, Osagie Ebekozien
-
Psychosocial Assessment Tools for Youth with Type 1 Diabetes: a 10-Year Review Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-11-24 Trevor Bell, Elizabeth Hazel
-
SHORT Syndrome: an Update on Pathogenesis and Clinical Spectrum Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-11-19 Naama Fisch Shvalb
-
Cellular Senescence in Obesity and Associated Complications: a New Therapeutic Target Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-10-14 Akilavalli Narasimhan, Rafael R. Flores, Christina D. Camell, David A. Bernlohr, Paul D. Robbins, Laura J. Niedernhofer
-
Systemic and Ocular Adverse Events with Intravitreal Anti-VEGF Therapy Used in the Treatment of Diabetic Retinopathy: a Review Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-09-02 Jason A. Zehden, Xavier M. Mortensen, Ashvini Reddy, Alice Yang Zhang
Purpose of Review Intravitreal anti-vascular endothelial growth factor (VEGF) agents are used routinely in the management of neovascular conditions including proliferative diabetic retinopathy and diabetic macular edema. While the efficacy of anti-VEGF agents has been well-validated, their ocular and systemic adverse events should always be considered and discussed with patients. The aim of this review
-
Social Care Recommendations in National Diabetes Treatment Guidelines Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-08-30 Benjamin Aceves, Rose Gunn, Maura Pisciotta, Na’amah Razon, Erika Cottrell, Danielle Hessler, Rachel Gold, Laura M. Gottlieb
-
Growth Hormone and Counterregulation in the Pathogenesis of Diabetes Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-08-24 Xuehong Dong, Lei Su, Mary-Elizabeth Patti
Purpose of Review Canonical growth hormone (GH)-dependent signaling is essential for growth and counterregulatory responses to hypoglycemia, but also may contribute to glucose homeostasis (even in the absence of hypoglycemia) via its impact on metabolism of carbohydrates, lipids and proteins, body composition, and cardiovascular risk profile. The aim of this review is to summarize recent data implicating
-
Potential Clinical Applications for Continuous Ketone Monitoring in the Hospitalized Patient with Diabetes Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-08-19 Michelle Jaromy, Joshua D. Miller
Purpose of Review In this review, the authors discuss potential clinical applications for continuous ketone monitoring (CKM) in a broad continuum of clinical settings from pre-hospital care and the emergency department to acute inpatient management and post-discharge follow-up. Recent Findings Though in its early stages, the concept of a novel continuous ketone sensing technology exerts great potential
-
Mindfulness-Based Interventions: Focus on Pediatric Type 1 and Type 2 Diabetes Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-08-19 Hailey Inverso, Hailey R. Moore, Francesca Lupini, Christine H. Wang, Randi Streisand, Lauren B. Shomaker, Eleanor R. Mackey
Purpose of Review Mindfulness-based interventions (MBIs) focus on promoting nonjudgmental, purposeful awareness of the present experience, and they include specific components such as body scan, meditation, and breathing techniques for healthier coping with stress and reduced negative affect. In adult populations with chronic illness (e.g., type 1 diabetes [T1D], type 2 diabetes [T2D], overweight)
-
Electronic Health Record–Based Decision-Making Support in Inpatient Diabetes Management Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-08-02 Johanna E. Gerwer, Grace Bacani, Patricia S. Juang, Kristen Kulasa
-
Evaluating Natural Experiments that Impact the Diabetes Epidemic: an Introduction to the NEXT-D3 Network Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-07-22 Karen R. Siegel, Mohammed K. Ali, Ronald T. Ackermann, Bernard Black, Nathalie Huguet, Abel Kho, Carol M. Mangione, Elizabeth Nauman, Dennis Ross-Degnan, Dean Schillinger, Lizheng Shi, J. Frank Wharam, O. Kenrik Duru
-
Pharmacist Role in Providing Inpatient Diabetes Management Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-07-13 J. T. Knezevich, A. C. Donihi, A. T. Drincic
-
Lipodystrophy for the Diabetologist—What to Look For Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-07-11 Nivedita Patni, Abhimanyu Garg
-
Content Validity of Patient-Reported Outcome Measures Developed for Assessing Health-Related Quality of Life in People with Type 2 Diabetes Mellitus: a Systematic Review Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-07-11 Caroline B. Terwee, Petra J. M. Elders, Marlous Langendoen-Gort, Ellen B. M. Elsman, Cecilia A. C. Prinsen, Amber A. van der Heijden, Maartje de Wit, Joline W. J. Beulens, Lidwine B. Mokkink, Femke Rutters
-
Telehealth for the Management of Diabetes in Pregnancy Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-07-09 Noelia M. Zork
Purpose of Review Telehealth initiatives are becoming ubiquitous in clinical practice and can be a useful tool in the management of diabetes in pregnancy. The purpose of this review is to summarize new techniques in telemedicine delivery and offer details on how to leverage telehealth in delivering care to pregnant women with diabetes. Recent Findings Using mobile phone technology to collect glucose
-
CGM in the Hospital: Is It Ready for Prime Time? Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-07-07 Elizabeth O. Buschur, Eileen Faulds, Kathleen Dungan
Purpose of Review The use of continuous glucose monitoring (CGM) in the hospital setting is growing with more patients using these devices at home and when admitted to the hospital, especially during the COVID-19 pandemic. Recent Findings Historically, most evidence for CGM use in the inpatient setting was limited to small studies utilizing outdated CGM technology and analyzing accuracy of sensor measurements
-
Diabetes Out-of-the-Box: Diabetes Mellitus and Impairment in Hearing and Vision Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-07-05 Noah Gruber, Orit Pinhas-Hamiel
-
Risk of Type 2 Diabetes Among Individuals with Excess Weight: Weight Trajectory Effects Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-07-04 Arthur H. Owora, David B. Allison, Xuan Zhang, Nana Gletsu-Miller, Kishore M. Gadde
-
Machine Learning Models for Inpatient Glucose Prediction Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-06-27 Andrew Zale, Nestoras Mathioudakis
-
Shift Work and Obesity Risk—Are There Sex Differences? Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-06-23 Kevin L. Smith, Alexandria B. Danyluk, Sanah S. Munir, Naima Covassin
-
Metabolic Syndrome and Vascular-Associated Cognitive Impairment: a Focus on Preclinical Investigations Curr. Diab. Rep. (IF 4.2) Pub Date : 2022-06-23 Trisha A. Jenkins
Purpose of Review Metabolic syndrome is associated with an increased risk of vascular cognitive impairment or, in the more extreme, vascular dementia. Animal models are used to investigate the relationship between pathology and behaviour. This review summarizes the latest understanding of the role of the hippocampus and prefrontal cortex in vascular cognitive impairment, the influence of inflammation